Incyte EVP files initial insider ownership: 67k shares reported
Rhea-AI Filing Summary
Form 3 filing snapshot: On 21 Jul 2025 Patrick A. Mayes—newly appointed EVP & Chief Scientific Officer of Incyte Corp. (INCY)—submitted his initial statement of beneficial ownership.
- Direct equity: 67,388 common shares, the bulk of which are restricted stock units scheduled to vest between 2025-2028.
- Derivative exposure: 57,080 employee stock options across 15 grants; strike prices range from $61.18 to $106.47 with expirations from 2027-2035. Most awards are either fully vested or vest monthly/annually over four years.
The filing establishes Mayes as a Section 16 insider and documents equity-based incentives that align his compensation with shareholder value. No purchases or sales occurred, so immediate market impact is minimal.
Positive
- Executive ownership of 67,388 shares and 57,080 options indicates meaningful equity alignment with shareholders.
Negative
- None.
Insights
TL;DR: Routine Form 3; new EVP discloses sizeable equity stake—governance compliance, low market impact.
This initial filing simply brings Patrick A. Mayes under Section 16 reporting following his promotion. The combined 67 k shares and 57 k options represent a meaningful personal stake but do not alter the firm’s capitalization. Strike dispersion (≈$61–$106) suggests upside-weighted incentives. Because there are no open-market transactions, the disclosure is informational rather than directional for investors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Employee Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This includes: 3,533 restricted stock units ("RSUs") granted on October 1, 2021 that will vest fully on October 1, 2025; 1,128 RSUs granted on July 2, 2022 that will fully on July 2, 2026; 3,079 RSUs granted on January 20, 2023 that will vest fully on January 20, 2027; 2,820 RSUs granted on July 14, 2023 that will vest 1,140 on July 14, 2026 and July 14, 2027; 5,253 RSUs granted on July 15, 2024 that will vest 1,751 on July 15, 2026, July 15, 2027 and July 15, 2028; 39,783 RSUs granted on June 6, 2025 that will vest fully on June 6, 2028; and 7,795 RSUs granted on July 15, 2025 that will vest 25% annually over four years. As of July 21st, 2025, the award is fully vested and exercisable Options granted on July 2, 2022 and will vest monthly through July 2, 2026 Options granted on January 20, 2023 and will vest monthly through July 2, 2026 Options granted on July 14, 2023 and will vest monthly through July 14, 2027 Options granted on January 18, 2024 and will vest monthly through July 14, 2027 Options granted on July 15, 2024 and will vest monthly through July 15, 2028 Options granted on January 17, 2025 and will vest monthly through July 15, 2028 Options granted on July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
